Email this article Contribution of intravenous immunoglobulins to the treatment of myasthenia (Ann. Med. Interne (Paris).— 2000. May. —151. Suppl. 1. — 1S30—4: Франц.)
- Authors: Gajdos P.1
-
Affiliations:
- Hopital Raymond-Poincare
- Issue: Vol XXXIII, No 1-2 (2001)
- Pages: 114-115
- Section: Articles
- URL: https://journals.rcsi.science/1027-4898/article/view/79794
- DOI: https://doi.org/10.17816/nb79794
- ID: 79794
Cite item
Full Text
Abstract
Myasthenia gravis is an autoimmune disease characterized by the production of autoantibodies against acetylcholine receptors at the end plate of the neuromuscular synapse.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
P. Gajdos
Hopital Raymond-Poincare
Author for correspondence.
Email: info@eco-vector.com
Service de Reanimation Medicale
France, GarchesReferences
